Skip to content

Endostapler Gastric Bypass Study

Safety and Efficacy of the AEON™ Endostapler in Laparoscopic Roux-en-Y Gastric Bypass Surgery

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04712526
Enrollment
0
Registered
2021-01-15
Start date
2021-01-18
Completion date
2023-12-31
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The goal of this prospective, post-market study is to evaluate safety and efficacy of the AEON™ Endostapler when used in laparoscopic Roux-en-Y gastric bypass surgery.

Detailed description

Stapler performance will be evaluated by incidence and degree of staple line bleeding from endoscopic and laparoscopic images, evaluated by a third-party. The study will include 25 total consecutive cases of individuals undergoing a planned laparoscopic Roux-en-Y gastric bypass (GB). The GB procedure will be performed according to institutional standard-of-care and all subjects will undergo standard preoperative evaluation as well as post-operative care.

Interventions

Surgery with AEON Endostapler

Sponsors

Lexington Medical Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing planned laparoscopic Roux-en-Y gastric bypass * Informed consent for study obtained and signed from each subject

Exclusion criteria

* Planned open surgical approach * Use of staple line reinforcement material (buttress) * Revision or other bariatric procedure * Patients with a bleeding disorder: known coagulopathy, or Platelets \<100,000, or PTT \> 45sec, or PT\> 15sec, or INR\>1.5 * Patients with active HIV or Hepatitis B * Patients under the age of 18 on the date of the surgery * Patients who are pregnant * Patients using tobacco products within the last 2 weeks prior to surgery date * Patients using cortisone or related products within the last 2 weeks prior to surgery date

Design outcomes

Primary

MeasureTime frame
Incidence of reported device-related adverse eventsWithin 30-day post-operative period

Secondary

MeasureTime frameDescription
Endoscopic staple line bleedingWithin surgeryIncidence of intraoperative staple line bleeding from endoscopic images as measured by the provided bleeding severity scale - Bleeding Severity Scale for Endoscope Images (1: No bleeding, 5: Profuse Bleeding)
Laparoscopic staple line bleedingWithin surgeryIncidence of intraoperative staple line bleeding from laparoscopic images as measured by the provided bleeding severity scale - Bleeding Severity Scale for Laparoscope Images (1: No bleeding, 5: Profuse Bleeding)
Incidence of intraoperative or postoperative blood transfusionWithin 72 hours of surgery start time
Incidence of product malfunctionWithin surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026